Corrigendum to “lenvatinib Plus Sintilimab Versus Lenvatinib Monotherapy As First-Line Treatment for Advanced HBV-related Hepatocellular Carcinoma: A Retrospective, Real-World Study” [heliyon 8 (6) (2022) E09538]
Heliyon（2022）
摘要
[This corrects the article DOI: 10.1016/j.heliyon.2022.e09538.].
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要